Kala Bio KALA
NASDAQ KALA
$0.17 +0.02 (+9.71%)
As of: Nov 9, 2026 · 10:49 AM EST

Kala Bio (KALA) Income towards Parent Company (2016 - 2026)

Updated

Analysis

Kala Bio (KALA) Income towards Parent Company (2016 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,246.02 Bn 1,219.64 Bn 20.46 Bn
2 Johnson & Johnson 671.05 Bn 590.91 Bn 17.30 Bn
3 AbbVie 513.91 Bn 481.92 Bn 13.12 Bn
4 Merck 363.65 Bn 326.59 Bn 13.19 Bn
5 Novartis Ag 314.67 Bn 287.91 Bn -
6 Astrazeneca 292.42 Bn 266.32 Bn 13.26 Bn
7 Amgen 249.03 Bn 200.69 Bn 7.58 Bn
8 Gilead Sciences 209.40 Bn 184.51 Bn 6.73 Bn
9 Pfizer 165.61 Bn 112.97 Bn 12.56 Bn
10 Kala Bio 2.61 Mn -42.03 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.58 Mn
Mar 31, 2026 -1.73 Mn
Dec 31, 2025 686,000.00
Sep 30, 2025 -7.56 Mn
Jun 30, 2025 -11.16 Mn
Mar 31, 2025 -8.95 Mn
Dec 31, 2024 -8.18 Mn
Sep 30, 2024 -8.95 Mn
Jun 30, 2024 -9.58 Mn
Mar 31, 2024 -11.81 Mn
Dec 31, 2023 -8.63 Mn
Sep 30, 2023 -8.70 Mn
Jun 30, 2023 -10.41 Mn
Mar 31, 2023 -14.46 Mn
Dec 31, 2022 -12.84 Mn
Sep 30, 2022 29.07 Mn
Jun 30, 2022 -28.11 Mn
Mar 31, 2022 -32.94 Mn
Dec 31, 2021 -47.57 Mn
Sep 30, 2021 -28.13 Mn
API Access

Kala Bio Income towards Parent Company API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=KALA&period=max&api_key=YOUR_API_KEY